Marc A. Rodwin (Suffolk University Law School) has posted Probing the Prevalence of Pharmaceutical Corruption, forthcoming in Journal of Law, Medicine and Ethics, Vol. 54, No. 2 (2026), on SSRN. Here is the abstract:
This article reviews the history and current evidence of systematic pharmaceutical industry corruption. It draws on studies by the OECD on international corruption; reports of the Securities and Exchange Commission; studies of the Public Citizen Health Research Group of settlement agreements between federal and state authorities and pharmaceutical firms; the history of the Medicare and Medicaid Anti-Kickback Act; professional and industry codes of ethics; the literature on institutional corruption; and studies of conflicts of interest. These sources support findings of systemic corruption since the mid-20th century. The paper also explores the relationship between classic corruption, institutional corruption and conflicts of interest in medicine and pharmaceutical policy.
Highly recommended!
To receive a daily summary of posts from Legal Theory Blog by email, get a free subscription to Legal Theory Stack.